Tag: FDA bioequivalence
Deficiency Letters in Generic Applications: Common FDA Findings and How to Avoid Them
FDA deficiency letters are a major hurdle for generic drugmakers. Learn the top 5 reasons applications get flagged - from dissolution issues to impurity controls - and how to avoid costly delays.
How Nurses Counsel Patients on Generic Medications: A Practical Guide
This article explains how nurses effectively counsel patients on generic medications, addressing common concerns and providing practical steps for improving adherence. It covers FDA standards, real-world examples, and tools nurses use to ensure patients understand therapeutic equivalence.